Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
J
Jürgens, Heribert
University Children’s Hospital Münster, West German Cancer Center Network, Department of Pediatric Hematology and Oncology, Münster, Germany
(
P 040
)
TWO RARE SIDES OF ONE RARE DISEASE: EWING SARCOMA WITH AND AS SECONDARY MALIGNANCIES FROM THE EPIDEMIOLOGICAL AND CLINICAL ANALYSIS OF AN INTERNATIONAL TRIAL REGISTRY
Heribert Jürgens
Favorite
Jürgens, Heribert
Department of Pediatric Hematology and Oncology, University Children’s Hospital Münster, West German Cancer Center Network
(
P 042
)
VALUE OF ADJUVANT RADIOTHERAPY IN PATIENTS WITH LOCALIZED EWING SARCOMA AT THE EXTREMITIES. REPORT FROM THE EWING 2008 TRIAL
Heribert Jürgens
Favorite
Jabado, Nada
Department of Pediatrics, McGill University
(
P 022
)
EZHIP ECTOPIC EXPRESSION AND ITS ROLE IN OSTEOSARCOMA PATHOGENESIS
Nada Jabado
Favorite
Jacobson, Mack
University of Calgary
(
P 205
)
PREOPERATIVE CHEMORADIATION (MODIFIED EILBER PROTOCOL) VERSUS NEOADJUVANT/ ADJUVANT RADIOTHERAPY FOR SOFT TISSUE EXTREMITY SARCOMAS: A POPULATION BASED ANALYSIS IN ALBERTA
Mack Jacobson
Favorite
Jaekers, Joris
UZ Leuven
(
P 198
)
XENOSARC: A PANEL OF PATIENT-DERIVED XENOGRAFT (PDX) MODELS OF SOFT TISSUE SARCOMA FOR PRECLINICAL DRUG EVALUATION
Joris Jaekers
Favorite
Jagosky, Megan
Levine Cancer Institute
(
P 261
)
CLINICAL FEATURES AND TREATMENT OUTCOMES OF PATIENTS WITH DESMOID TUMORS: A LARGE SINGLE INSTITUTION RETROSPECTIVE SERIES
Megan Jagosky
Favorite
Jain, Ashutosh
Tata Memorial Centre
(
P 03
)
DEMOGRAPHICS, PRACTICE PATTERNS, CHALLENGES AND OUTCOMES OF SYNOVIAL SARCOMA PATIENTS FROM A TERTIARY CARE CENTRE FROM A LARGE LOW-MIDDLE INCOME COUNTRY
Ashutosh Jain
Favorite
Jakob, Jens
Sarcoma Center, Dept. of Surgery, Mannheim University Medical Center
(
P 264
)
DESMOID AND TRAUMA: REAL INCIDENCE AND MEDICOLEGAL ASPECTS OF CAUSALITY
Jens Jakob
Favorite
Jakub, James
Mayo Clinic (Jacksonville)
(
P 289
)
MERKEL CELL CARCINOMA OF UNKNOWN PRIMARY: CLINICAL PRESENTATION AND OUTCOMES
James Jakub
Favorite
Jalmsell, Li
Advanced Home Care Team
(
P 204
)
PERCEPTIONS AND MANAGEMENT PRACTICES OF SARCOMA EXPERTS ABOUT SOFT TISSUE SARCOMA PATIENTS WITH ISOLATED LUNG METASTASES ACROSS EUROPE
Li Jalmsell
Favorite
Janeway, Katherine
Dana Farber / Boston Children's Cancer and Blood Disorders Center
(
P 323
)
PHASE 2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY EWING SARCOMA.
Katherine Janeway
Favorite
Janeway, Katie
Dana-Farber and Children's Hospital
(
P 023
)
FACTORS ASSOCIATED WITH LOCAL CONTROL AND SURVIVAL IN LOCALIZED EWING SARCOMA PATIENTS TREATED WITH SURGERY ON AEWS1031: A REPORT FROM THE CHILDRENS ONCOLOGY GROUP
Katie Janeway
Favorite
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
Katie Janeway
Favorite
(
P 310
)
TUMOR REVIEW BOARD FOR OSTEOSARCOMA (TURBO): BIMONTHLY, MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR OSTEOSARCOMA
Katie Janeway
Favorite
Jarecha, Rudresh
Deciphera Pharmaceuticals, LLC
(
P 102
)
EFFICACY AND SAFETY OF VIMSELTINIB IN TENOSYNOVIAL GIANT CELL TUMOUR: PHASE 2 EXPANSION
Rudresh Jarecha
Favorite
Javid, Sara
University of Washington/Fred Hutch Cancer Center
(
P 063
)
A RETROSPECTIVE COHORT ANALYSIS EVALUATING THE NATURAL HISTORY AND CHARACTERISTICS OF ANGIOSARCOMAS OF THE BREAST
Sara Javid
Favorite
Jawhar, Wajih
Department of Experimental Medicine, McGill University
(
P 022
)
EZHIP ECTOPIC EXPRESSION AND ITS ROLE IN OSTEOSARCOMA PATHOGENESIS
Wajih Jawhar
Favorite
(
P 030
)
OSTEOSARCOMA PATIENT-DERIVED-XENOGRAFTS A RELEVANT MODEL TO STUDY CHEMOTHERAPEUTIC AND METASTATIC EVENTS
Wajih Jawhar
Favorite
(
P 232
)
DECIPHERING METASTASIS MAINTENANCE AND CHEMO RESISTANCE EVENTS IN CIC-DUX4 SARCOMA
Wajih Jawhar
Favorite
Jean-Denis, Myriam
Department of Biopathology, CLCC Léon Bérard, Lyon University, Lyon, France & CRCL, University Claude Bernard Lyon 1, Lyon, France
(
P 245
)
MUTATIONAL STATUS OF CHONDROSARCOMA BASED ON TARGETED NEXT-GENERATION SEQUENCING ANALYSIS
Myriam Jean-Denis
Favorite
Jeffe, Donna
Washington University in St. Louis
(
P 075
)
EXAMINING PATIENT PERSPECTIVES ON SARCOMA SURVEILLANCE: THE SARCOMA SURVEILLANCE SURVEY
Donna Jeffe
Favorite
JEHANNO, Nina
Institut Curie
(
P 026
)
IS THERE STILL A PLACE FOR BONE MARROW SAMPLING IN VERY HIGH RISK EWING SARCOMA? ROLE OF FDG PET/CT IN THE INITIAL STAGING OF VERY HIGH RISK EWING SARCOMA IN A PROSPECTIVE PHASE II MULTICENTRIC STUDY.
Nina JEHANNO
Favorite
Jimenez, M.Dolores
HCU VIRGEN ARRIXACA
(
P 318
)
NEOADJUVANT CHEMORADIOTHERAPY IN ADVANCED SOFT TISSUE SARCOMA. UPDATED NASAR STUDY
M.Dolores Jimenez
Favorite
Jin, Dexter
Foundation Medicine Inc.
(
P 177
)
GENOMIC LANDSCAPE OF RARE EWSR1 FUSIONS
Dexter Jin
Favorite
(
P 256
)
TUMOR MUTATIONAL BURDEN AND MICROSATELLITE INSTABILITY IN LEIOMYOSARCOMA
Dexter Jin
Favorite
Jirovec, Anna
Ottawa Hospital Research Institute
(
P 197
)
TUMOR IMMNUNE PROFILING AND IDENTIFICATION OF IMMUNOTHERAPEUTIC TARGETS IN DEDIFFERENTIATED LIPOSARCOMA
Anna Jirovec
Favorite
Jodeh, Diana
Johns Hopkins All Children's Hospital
(
P 305
)
THE INCIDENCE OF THROMBOEMBOLIC EVENTS DURING HOSPITALIZATIONS FOLLOWING SURGICAL RESECTION OF LOWER EXTREMITY SARCOMAS IN CHILDREN: UTILIZING THE PEDIATRIC HEALTH INFORMATION SYSTEM (PHIS) DATABASE
Diana Jodeh
Favorite
John, Samuel
University of Texas Southwestern Medical Center
(
P 104
)
INFANTILE EXTRARENAL SPINDLE CELL MESENCHYMAL NEOPLASMS WITH TARGETABLE EGFR KINASE DOMAIN DUPLICATIONS
Samuel John
Favorite
Johnson, Bruce
Dana-Farber Cancer Institute
(
P 239
)
FGFR IS A RELEVANT MOLECULAR TARGET IN PEDIATRIC AND AYA SARCOMAS
Bruce Johnson
Favorite
Johnson, Debbie
IDRx, Inc
(
P 316
)
FIRST-IN-HUMAN PHASE 1/1B STUDY OF IDRX-42, A NOVEL ORAL TYROSINE KINASE KIT INHIBITOR, IN PARTICIPANTS WITH METASTATIC AND/OR UNRESECTABLE GASTROINTESTINAL STROMAL TUMORS
Debbie Johnson
Favorite
Johnson, Melissa
Sarah Cannon Research Institute
(
P 127
)
IDENTIFYING MAGE-A4-POSITIVE TUMORS FOR SPEAR T-CELL THERAPIES IN HLA-A*02-ELIGIBLE PATIENTS
Melissa Johnson
Favorite
Jonczak, Emily
University of Miami
(
P 07
)
HETEROGENEITY IN TREATMENT REGIMENS FOR AYA BONE SARCOMAS: A COMPARISON OF OUTCOMES AT A SINGLE SARCOMA CENTER
Emily Jonczak
Favorite
Jonczak, Emily
Sylvester Comprehensive Cancer Center
(
P 070
)
COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT TREATMENT IN SOFT TISSUE SARCOMA. A SINGLE INSTITUTION EXPERIENCE.
Emily Jonczak
Favorite
(
P 234
)
DNA DAMAGE RESPONSE PATHWAYS IN SYNOVIAL SARCOMA
Emily Jonczak
Favorite
Jonczak, Emily
University of Miami/Sylvester Comprehensive Cancer Center
(
P 263
)
COMPARATIVE EFFECTIVENESS OF SYSTEMIC TREATMENTS IN DESMOID TUMORS
Emily Jonczak
Favorite
Jones, Conor
Rush University Medical Center
(
P 081
)
MISSING DATA IN THE DEVELOPMENT AND EXTERNAL VALIDATION OF MACHINE LEARNING MODELS FOR SURVIVAL PREDICTION IN SARCOMA
Conor Jones
Favorite
(
P 206
)
RADIOTHERAPY LEADS TO IMPROVED OVERALL SURVIVAL IN PATIENTS UNDERGOING RESECTION FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Conor Jones
Favorite
(
P 227
)
ASSOCIATION BETWEEN NEUTROPHIL-LYMPHOCYTE RATIO, PLATELET-LYMPHOCYTE RATIO, AND SURVIVAL IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Conor Jones
Favorite
Jones, Kevin
Huntsman Cancer Institute
(
P 306
)
THERMAL NECROSIS IN ORTHOPAEDIC BONE TUMORS
Kevin Jones
Favorite
Jones, Robin
The Royal Marsden NHS Foundation Trust
(
P 061
)
UNRAVELLING THE HETEROGENEITY OF THE IMMUNE MICROENVIRONMENT IN STS USING QUANTITATIVE MRI
Robin Jones
Favorite
(
P 085
)
RADIATION ASSOCIATED ANGIOSARCOMAS OF THE BREAST: MULTIFOCALITY WARRANTS AGGRESSIVE ONCOLOGICAL STRATEGY
Robin Jones
Favorite
(
P 152
)
FINAL RESULTS OF GEMMK: A PHASE I TRIAL OF GEMCITABINE AND PEMBROLIZUMAB IN PATIENTS WITH LEIOMYOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Robin Jones
Favorite
Jones, Robin Lewis
Royal Marsden Hospital and Institute of Cancer Research
(
P 188
)
PRELIMINARY ASSESSMENT OF CIRCULATING INFLAMMATORY CYTOKINES IN EPITHELIOID HEMANGIOENDOTHELIOMA (EHE) PATIENTS AND IN AN EHE PATIENT-DERIVED XENOGRAFT BEFORE AND AFTER DOXORUBICIN AND SIROLIMUS
Robin Lewis Jones
Favorite
(
P 204
)
PERCEPTIONS AND MANAGEMENT PRACTICES OF SARCOMA EXPERTS ABOUT SOFT TISSUE SARCOMA PATIENTS WITH ISOLATED LUNG METASTASES ACROSS EUROPE
Robin Lewis Jones
Favorite
(
P 268
)
INITIAL RESULTS OF PHASE 2/3 TRIAL OF AL102 FOR TREATMENT OF DESMOID TUMORS (DT)
Robin Lewis Jones
Favorite
(
P 315
)
A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL OF INBRX-109 IN UNRESECTABLE OR METASTATIC CONVENTIONAL CHONDROSARCOMA
Robin Lewis Jones
Favorite
(
P 320
)
PEAK STUDY: A PHASE 3 RANDOMIZED, OPEN-LABEL, MULTICENTER CLINICAL STUDY OF BEZUCLASTINIB (CGT9486) AND SUNITINIB VERSUS SUNITINIB IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS
Robin Lewis Jones
Favorite
Jordaan, Pierre
Monopar Therapeutics, Inc.
(
P 321
)
PHASE 1B TRIAL OF CAMSIRUBICIN, A NOVEL DOXORUBICIN ANALOG, WITH CONCOMITANT PEGFILGRASTIM FOR ADVANCED SOFT TISSUE SARCOMA TO IDENTIFY A NEW MAXIMUM TOLERATED DOSE/RECOMMENDED PHASE 2 DOSE.
Pierre Jordaan
Favorite
Jorgensen, Malene M.
Department of Clinical Immunology, Aalborg University Hospital
(
P 120
)
THE DIAGNOSTIC AND PROGNOSTIC VALUE OF PLASMA SMALL EXTRACELLULAR VESICLES PHENOTYPE IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMOUR
Malene M. Jorgensen
Favorite
Joshi, Amit
Tata Memorial Centre
(
P 03
)
DEMOGRAPHICS, PRACTICE PATTERNS, CHALLENGES AND OUTCOMES OF SYNOVIAL SARCOMA PATIENTS FROM A TERTIARY CARE CENTRE FROM A LARGE LOW-MIDDLE INCOME COUNTRY
Amit Joshi
Favorite
Jo, Sung Jun
Samsung Medical Center
(
P 212
)
COMPARISON OF SURGICAL OUTCOMES BETWEEN LEIOMYOSARCOMA OF INFERIOR VENA CAVA AND OTHER LOCATIONS
Sung Jun Jo
Favorite
(
P 215
)
FEASIBILITY AND ADVANTAGE OF PRE-OPERATIVE RADIOTHERAPY IN RETROPERITONEAL SARCOMA
Sung Jun Jo
Favorite
Jung, Sin-Ho
Duke
(
P 034
)
REGIONAL ANESTHESIA IMPROVES METASTASIS FREE SURVIVAL AFTER SURGICAL RESECTION OF BONE SARCOMAS
Sin-Ho Jung
Favorite
Jung, Sungmi
McGill University
(
P 022
)
EZHIP ECTOPIC EXPRESSION AND ITS ROLE IN OSTEOSARCOMA PATHOGENESIS
Sungmi Jung
Favorite
Jung, Sung-Mi
Department of Pathology, McGill University Health Centre
(
P 030
)
OSTEOSARCOMA PATIENT-DERIVED-XENOGRAFTS A RELEVANT MODEL TO STUDY CHEMOTHERAPEUTIC AND METASTATIC EVENTS
Sung-Mi Jung
Favorite
Justice, Ryli
Indiana University
(
P 192
)
TARGETING PI3K/MTOR MITIGATES RESISTANCE TO CDK4/6 INHIBITION IN RB-PROFICIENT PEDIATRIC AND AYA OSTEOSARCOMAS
Ryli Justice
Favorite
Juszczak-Kosela, Katarzyna
Pfizer Inc
(
P 323
)
PHASE 2 STUDY TO EVALUATE PALBOCICLIB (IBRANCE®) IN COMBINATION WITH IRINOTECAN AND TEMOZOLOMIDE IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY EWING SARCOMA.
Katarzyna Juszczak-Kosela
Favorite
Back to Top
